OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
February 09, 2023
Examining efforts to boost women representation on company boards.
November 08, 2022
The validity of ESG-driven investment and reporting in healthcare.
September 09, 2022
A prime opportunity for pharma to raise its strategic game in ESG.
August 24, 2022
U.S. patent law will have to adapt to the use of AI in the life sciences industry.
August 10, 2022
How principles of both can help companies navigate future storms.
July 26, 2022
July 08, 2022
Issue represents a potential threat in fighting future pandemics.
Pharma companies should review their commission-based compensation arrangements with independent contractors to address enforcement risk under the Anti-Kickback Statute, in light of recent Department of Justice enforcement.
May 11, 2022
Instead, incorporate ESG into your long-term business planning.
May 02, 2022
Role drift and clinical trials among many areas for compliance professionals to keep an eye on in 2022.